Daniel C. Beachler, PhD, MHS

Director, Safety & Epidemiology
HealthCore Inc.
Wilmington, Delaware, United States

Daniel C. Beachler, PhD, MHS is an associate director in the Safety & Epidemiology department at HealthCore Inc. He leads pharmacoepidemiology research studies supporting medical product safety in both chronic and infectious disease areas. He has experience conducting validation studies and utilizing predictive modeling and machine learning methods in order to develop claims-based algorithms to improve cohort and outcome classification. He has also been involved with post authorization safety studies (PASS), Risk Evaluation and Mitigation Strategy (REMS), post-market requirement (PMR) studies. Prior to joining HealthCore, Dr. Beachler was a Cancer Prevention Fellow at the National Cancer Institute, Division of Cancer Epidemiology and Genetics. He holds a MHS and PhD in Epidemiology from Johns Hopkins School of Public Health and a BS in Bioengineering from The Pennsylvania State University.

HealthCore Inc. (Subsidiary of Anthem Inc.) (Employment)

Presentation(s):

• Using Pharmacoepidemiology Database Resources to Address Drug Safety Research

  Wednesday, August 24, 2022
  2:00 PM – 6:00 PM CEST

• Adjusting for Data Observation Delay in near Real-time Safety Surveillance of COVID-19 Vaccines Using Administrative Claims Databases

  Friday, August 26, 2022
  6:15 PM – 6:30 PM CEST

• Evaluation of Mortality Data Sources Compared to the National Death Index in the Healthcore Integrated Research Database

  Sunday, August 28, 2022
  8:45 AM – 9:00 AM CEST